![Daniel Karp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Karp
Direktör/Styrelseledamot på
CARTESIAN GROWTH CORPORATION II
Förmögenhet: 942 375 $ per 2026-07-31
Profil
Daniel Karp is currently an Independent Director at Cartesian Growth Corp.
II since 2022 and Executive Vice President-Corporate Development at Organon & Co. Former positions include Independent Director at Cartesian Growth Corp., Vice President-Worldwide Business Development at Pfizer Inc. from 2016 to 2018, and Executive Vice President-Corporate Development at Biogen, Inc. from 2018 to 2020.
Education includes an undergraduate degree from Duke University and an MBA from The Wharton School of the University of Pennsylvania.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ORGANON & CO. 0,03 % | 2026-06-15 | 69 548 ( 0,03 % ) | 942 375 $ | 2026-07-31 |
Aktiva positioner av Daniel Karp
| Företag | Position | Start |
|---|---|---|
| CARTESIAN GROWTH CORPORATION II | Direktör/Styrelseledamot | 2022-05-01 |
| ORGANON & CO. | Företagsledare/Principal | - |
Tidigare kända positioner av Daniel Karp
| Företag | Position | Slut |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | 2020-05-01 |
| PFIZER INC. | Företagsledare/Principal | 2018-06-01 |
| ALVARIUM TIEDEMANN A | Direktör/Styrelseledamot | - |
Daniel Karps utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
99
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cartesian Growth Corp.
 Cartesian Growth Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Organon & Co.
 Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Cartesian Growth Corp. II
 Cartesian Growth Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
